Wells Fargo & Company Has Lowered Expectations for Amphastar Pharmaceuticals (NASDAQ:AMPH) Stock Price
Amphastar Pharmaceuticals (NASDAQ:AMPH – Get Free Report) had its price target reduced by research analysts at Wells Fargo & Company from $40.00 to $35.00 in a research report issued to clients and investors on Thursday,Benzinga reports. The firm currently has an “overweight” rating on the stock. Wells Fargo & Company‘s price target points to a […]
Amphastar Pharmaceuticals (NASDAQ:AMPH – Get Free Report) had its price target reduced by research analysts at Wells Fargo & Company from $40.00 to $35.00 in a research report issued to clients and investors on Thursday,Benzinga reports. The firm currently has an “overweight” rating on the stock. Wells Fargo & Company‘s price target points to a […]
